These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Creation of TNFR1-selective antagonist and its therapeutic effects]. Nomura T; Abe Y; Yoshioka Y; Nakagawa S; Tsunoda S; Tsutsumi Y Yakugaku Zasshi; 2010 Jan; 130(1):63-8. PubMed ID: 20046067 [TBL] [Abstract][Full Text] [Related]
15. Mutants of lymphotoxin-α with augmented cytotoxic activity via TNFR1 for use in cancer therapy. Morishige T; Yoshioka Y; Narimatsu S; Ikemizu S; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S Cytokine; 2013 Feb; 61(2):578-84. PubMed ID: 23246116 [TBL] [Abstract][Full Text] [Related]
16. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action. Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365 [TBL] [Abstract][Full Text] [Related]
17. Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1. Hu Z; Qin J; Zhang H; Wang D; Hua Y; Ding J; Shan L; Jin H; Zhang J; Zhang W Biochem Pharmacol; 2012 Dec; 84(11):1482-91. PubMed ID: 22981364 [TBL] [Abstract][Full Text] [Related]
18. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides. Qin W; Feng J; Li Y; Lin Z; Shen B Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837 [TBL] [Abstract][Full Text] [Related]
19. Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Dong Y; Fischer R; Naudé PJ; Maier O; Nyakas C; Duffey M; Van der Zee EA; Dekens D; Douwenga W; Herrmann A; Guenzi E; Kontermann RE; Pfizenmaier K; Eisel UL Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12304-12309. PubMed ID: 27791020 [TBL] [Abstract][Full Text] [Related]
20. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy. Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]